UK to offer new vaccine shots to Novavax trial volunteers

Britain says it it will offer new vaccinations to thousands of people who volunteered for trials of the Novavax coronavirus vaccine, which has not yet been approved for use in any country

Via AP news wire
Friday 08 October 2021 14:19
Virus Outbreak Britain
Virus Outbreak Britain

Britain announced Friday that it will offer new vaccinations to thousands of people who volunteered for trials of the Novavax coronavirus vaccine, which hasn't yet been approved for use in any country.

Around 15,000 people in the U.K. got Novavax shots as part of a clinical trial. While the U.K. recognizes them as vaccinated, most countries don’t, meaning they can’t travel.

Britain’s health department said more than 15,000 participants will be given two doses of the Pfizer BioNTech vaccine. The government says it plans to expand the offer to about 6,000 U.K. participants in trials of other vaccines that also haven't been approved for use.

Britain has appealed to other members of the Group of 20 nations to classify clinical trial volunteers as vaccinated, but most haven't done so.

England’s deputy chief medical officer, Jonathan Van-Tam noted that “if more countries around the world had reciprocated by allowing U.K. volunteers to enjoy fully vaccinated status for overseas travel, these measures would not have been necessary.”

In June, Novavax announced that its vaccine had proved about 90% effective against symptomatic COVID-19 in a study of nearly 30,000 people in the U.S. and Mexico.

U.S.-based Novavax has asked the World Health Organization to approve its COVID-19 vaccine for emergency use so it can be part of the COVAX global vaccine program. But it has delayed seeking approval in Europe or the United States.

The Novavax shots are easier to store and transport than some other options, and have long been expected to play an important role in increasing supplies in poor countries desperate for more vaccine doses.

___

Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in